VIEWPOINT Nephrology research-the past, present and future

被引:20
|
作者
Floege, Juergen [1 ]
Mak, Robert H. [2 ]
Molitoris, Bruce A. [3 ]
Remuzzi, Giuseppe [4 ]
Ronco, Pierre [5 ,6 ,7 ]
机构
[1] Rhein Westfal TH Aachen, Div Nephrol & Immunol, D-52074 Aachen, Germany
[2] Univ Calif San Diego, Rady Childrens Hosp, Div Paediat Nephrol, La Jolla, CA 92093 USA
[3] Indiana Univ Sch Med, Dept Med, Div Nephrol, Indianapolis, IN 46202 USA
[4] Ctr Anna Maria Astori, IRCCS Ist Ric Farmacol Mario Negri, Clin Res Ctr Rare Dis Aldo & Cele Dacco, I-24126 Bergamo, Italy
[5] INSERM, UMR S 1155, F-75020 Paris, France
[6] Univ Paris 06, F-75020 Paris, France
[7] Tenon Hosp, AP HP, Div Nephrol, F-75020 Paris, France
基金
美国国家卫生研究院;
关键词
BLOOD-PRESSURE CONTROL; KIDNEY-DISEASE; GLOMERULAR PROTEIN; PROGRESSION; ECULIZUMAB; BIOMARKERS; GLOMERULONEPHRITIS; NEPHROPATHY; VARIANTS; VOLUME;
D O I
10.1038/nrneph.2015.152
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Important advances have been made in basic and clinical nephrology research over the past decade, with improved pathological insights into various disease processes and the introduction of new treatments for diseases such as atypical haemolytic uraemic syndrome. However, many challenges remain. In this Viewpoint, we asked five Nature Reviews Nephrology Advisory Board members, who have been associated with the journal since its launch in November 2005, to reflect on the progress and roadblocks of the past 10 years. They also comment on areas where effort and money should be invested and how they expect the field to progress in the next 10 years.
引用
收藏
页码:677 / 687
页数:11
相关论文
共 50 条
  • [31] Vascular cognitive impairment - Past, present, and future challenges
    Badji, Atef
    Youwakim, Jessica
    Cooper, Alexandra
    Westman, Eric
    Marseglia, Anna
    AGEING RESEARCH REVIEWS, 2023, 90
  • [32] Glycomic analysis of ovarian cancer: Past, present, and future
    Abbott, Karen L.
    CANCER BIOMARKERS, 2010, 8 (4-5) : 273 - 280
  • [33] The Past, the Present, and the Future of Genomic Therapies in Cardiovascular Disease
    Mcnally, Elizabeth M.
    Puckelwartz, Megan J.
    Nobrega, Marcelo A.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (23):
  • [34] Clinical trials in gynecologic oncology: Past, present, and future
    Annunziata, Christina M.
    Kohn, Elise C.
    GYNECOLOGIC ONCOLOGY, 2018, 148 (02) : 393 - 402
  • [35] The Journey of "Geographic Atrophy" through Past, Present, and Future
    Schmitz-Valckenberg, Steffen
    OPHTHALMOLOGICA, 2017, 237 (01) : 11 - 20
  • [36] Eculizumab and Beyond: The Past, Present, and Future of Complement Therapeutics
    Patriquin, Christopher J.
    Kuo, Kevin H. M.
    TRANSFUSION MEDICINE REVIEWS, 2019, 33 (04) : 256 - 265
  • [37] Troponin as a Biomarker of Cardiac Toxicity: Past, Present, and Future
    Reagan, William J.
    TOXICOLOGIC PATHOLOGY, 2010, 38 (07) : 1134 - 1137
  • [38] Renal Disease in the Caribbean The Disease of the Past, Present and Future
    Soyibo, A. K.
    Roberts, L.
    Douglas, L. L.
    Barton, E. N.
    WEST INDIAN MEDICAL JOURNAL, 2012, 61 (04) : 418 - 421
  • [39] The Chairside Periodontal Diagnostic Toolkit: Past, Present, and Future
    Ko, Tae-Jun
    Byrd, Kevin M.
    Kim, Shin Ae
    DIAGNOSTICS, 2021, 11 (06)
  • [40] Circulating Neuroendocrine Tumor Biomarkers: Past, Present and Future
    Komarnicki, Pawel
    Musialkiewicz, Jan
    Stanska, Alicja
    Maciejewski, Adam
    Gut, Pawel
    Mastorakos, George
    Ruchala, Marek
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (19)